大公司创新情报（2月21日）：翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市

亿欧02-21

今日看点翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密(002475.SZ)港股IPO招股书失效今日情报（2家2条）翰森制药翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密立讯精密(002475.SZ)港股IPO招股书失效回顾2月20日大公司创新情报，请点击大公司创新情报（2月20日）：五粮液：公司暂无设立投资公司计划，资金以服务主业为核心大公司创新情报是亿欧数据推出的一款...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2613122360?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-21 17:37","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2613122360","market":"hk","top_or_hot":-1,"title":"大公司创新情报（2月21日）：翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市","media":"亿欧","content":"<div>\n<p>今日看点翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密(002475.SZ)港股IPO招股书失效今日情报（2家2条）翰森制药翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密立讯精密(002475.SZ)港股IPO招股书失效回顾2月20日大公司创新情报，请点击 大公司创新情报（2月20日）：五粮液：公司暂无设立投资公司计划，资金以服务主业为核心大公司创新情报是亿欧数据推出的一款...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221173952a70fe885&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>大公司创新情报（2月21日）：翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n大公司创新情报（2月21日）：翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-21 17:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221173952a70fe885&s=b><strong>亿欧</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>今日看点翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密(002475.SZ)港股IPO招股书失效今日情报（2家2条）翰森制药翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密立讯精密(002475.SZ)港股IPO招股书失效回顾2月20日大公司创新情报，请点击 大公司创新情报（2月20日）：五粮液：公司暂无设立投资公司计划，资金以服务主业为核心大公司创新情报是亿欧数据推出的一款信息...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221173952a70fe885&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221173952a70fe885&s=b","article_id":"2613122360","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221173952a70fe885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2613122360","pubTimestamp":1771666624,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"今日看点翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密港股IPO招股书失效今日情报翰森制药翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密立讯精密港股IPO招股书失效回顾2月20日大公司创新情报，请点击 大公司创新情报：五粮液：公司暂无设立投资公司计划，资金以服务主业为核心大公司创新情报是亿欧数据推出的一款信息服务产品，为您网罗国内知名大公司的创新动态，持续追踪各领域的新技术新模式。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1583":"高瓴概念","BK1589":"北水核心资产","03692":"翰森制药","BK1191":"制药"},"translate_title":"Innovation intelligence of large companies (February 21): Hansoh Pharmaceuticals: Ametinib mesylate tablets as monotherapy approved for marketing in the EU","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1.5},"content_text":"今日看点翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密(002475.SZ)港股IPO招股书失效今日情报（2家2条）翰森制药翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密立讯精密(002475.SZ)港股IPO招股书失效回顾2月20日大公司创新情报，请点击 大公司创新情报（2月20日）：五粮液：公司暂无设立投资公司计划，资金以服务主业为核心大公司创新情报是亿欧数据推出的一款信息服务产品，为您网罗国内知名大公司的创新动态，持续追踪各领域的新技术新模式。本文由亿欧数据机器人自动发布，如有问题请和我们联系。 亿欧数据致力于为能引领科技和产业发展的组织，提供好用的行业洞察工具，高效的商业决策服务。想要定制您的专属情报，欢迎访问亿欧数据或联系我们。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2613122360","isCrawlerRequest":true}